Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Nov 3;14:17562864211054952. doi: 10.1177/17562864211054952

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s), 2021

This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).

PMC Copyright notice

Figure 2. — Treatment effects on pNfL and pGFAP levels in follow-up. On treatment effects of tocilizumab and rituximab on pNfL and pGFAP levels were compared to Prednisone, the figures show the original, untransformed data with geometric means of NfL with 95% confidence intervals, p values were from mixed models for repeated measurements of log-NfL and log-GFAP. Dotted line represents plasma NfL (geometric means) concentrations in healthy controls; GFAP, glial fibrillary acidic protein; n, number of evaluable samples; NfL, neurofilament light chain.